145 related articles for article (PubMed ID: 6354520)
1. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
Takemura J; Seino Y; Yamamura T; Yoshiya K; Ishikawa Y; Itoh N; Imura H
Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
[TBL] [Abstract][Full Text] [Related]
2. The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis.
Takemura J; Seino Y; Yamamura T; Tsuda K; Seino S; Itoh N; Imura H
J Clin Endocrinol Metab; 1982 May; 54(5):909-13. PubMed ID: 7037822
[TBL] [Abstract][Full Text] [Related]
3. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
Lauritsen KB; Moody AJ
Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
[TBL] [Abstract][Full Text] [Related]
5. Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy.
Lauritsen KB; Moesgaard F; Nielsen ML; Jensen SL
Scand J Gastroenterol; 1982 Jun; 17(4):507-11. PubMed ID: 6753107
[TBL] [Abstract][Full Text] [Related]
6. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
7. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
[TBL] [Abstract][Full Text] [Related]
8. The correlation between gastric emptying time and the response of GIP and enteroglucagon to oral glucose in duodenal ulcer patients.
Lauritsen KB; Frederiksen HJ; Uhrenholdt A; Holst JJ
Scand J Gastroenterol; 1982 Jun; 17(4):513-6. PubMed ID: 6753108
[TBL] [Abstract][Full Text] [Related]
9. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of gastric inhibitory polypeptide in normal and duodenal ulcer patients.
Cataland S; O'Dorisio TM; Brooks R; Mekhjian HS
Gastroenterology; 1977 Jul; 73(1):19-22. PubMed ID: 863190
[TBL] [Abstract][Full Text] [Related]
11. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
12. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
Jorde R; Schulz TB; Burhol PG; Schulz LB
Regul Pept; 1981 Nov; 2(6):391-9. PubMed ID: 7029674
[TBL] [Abstract][Full Text] [Related]
13. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
[TBL] [Abstract][Full Text] [Related]
14. [The effect of selective proximal vagotomy on gastrin, GIP and insulin blood levels in patients with duodenal ulcer].
Börger HW; Schafmayer A; Becker HD
Chir Forum Exp Klin Forsch; 1978; (1978):25-9. PubMed ID: 752595
[TBL] [Abstract][Full Text] [Related]
15. [Gastric inhibitory polypeptide (GIP) (author's transl].
Ebert R; Finke U
Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
[TBL] [Abstract][Full Text] [Related]
16. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with gastric inhibitory polypeptide.
Brown JC; Otte S
World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
[TBL] [Abstract][Full Text] [Related]
18. Gastric inhibitory polypeptide.
Ebert R; Creutzfeldt W
Clin Gastroenterol; 1980 Sep; 9(3):679-98. PubMed ID: 6107191
[TBL] [Abstract][Full Text] [Related]
19. Influence of vagotomy upon GIP release in patients with peptic ulcer.
Imamura M; Kameyama J; Naito H; Sato T; Ohneda A
Tohoku J Exp Med; 1984 Jul; 143(3):335-44. PubMed ID: 6385345
[TBL] [Abstract][Full Text] [Related]
20. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y; Furukawa Y; Sato T; Yumita S; Bloom SR
Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):98-109. PubMed ID: 7044844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
